Why is Cohance Life falling/rising?

As of 12-Aug, Cohance Lifesciences Ltd's stock price is currently at Rs 948.95, reflecting an increase of 9.2 points or 0.98%. The stock has shown a positive performance today, having outperformed its sector by 0.6% and opened with a gain of 4.48%. It has been gaining for the last two days, resulting in a total return of 2.59% during this period. However, despite this recent uptick, the stock is still 4% away from its 52-week low and has experienced a decline of 5.95% over the past month. The company has a high management efficiency with a return on equity (ROE) of 22.91% and a low debt-to-equity ratio, which are positive indicators. Nonetheless, the long-term growth outlook appears poor, with operating profit declining at an annual rate of -3.76% over the last five years, and profits have fallen by -10.8% over the past year.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has declined by only 0.59% over the past week and 2.75% over the past month. This suggests that while Cohance Lifesciences Ltd is experiencing a short-term rebound, it has underperformed the market over longer periods, with a year-to-date return of -16.27% compared to the Sensex's gain of 2.68%. The falling investor participation, indicated by a significant drop in delivery volume, raises concerns about the stock's liquidity and overall market interest. Despite the recent gains, the stock's valuation remains high compared to its peers, which may deter potential investors looking for value.